CareDx, Inc. (CDNA)
CareDx, Inc. (CDNA) from its SEC filings: 2025 revenue $379.8 million (+14% vs the year before), net margin -6%, free cash flow $42.0 million. Insider trades, recent filings and a price chart. Free.
| Exchange | Nasdaq |
| Industry | Services-Medical Laboratories |
| Revenue (2025) | $379.8 million |
| Revenue growth | +14% |
| Net income | -$21.4 million |
| Net margin | -5.6% |
| Free cash flow | $42.0 million |
| Diluted EPS | $-0.40 |
| Latest quarter (Q2 2026 (calendar)) revenue vs a year earlier | +52% |
| Cash | $373.6 million |
| Long-term debt | $0 |
| Share count, 1 year | -3% |
| Fundamentals check | Strong fundamentals |
Source: SEC EDGAR company filings (XBRL), updated 2026-10-23. Education only, not financial advice.